Webinar: Pediatric Behavioral Health; Best Practices for Primary Care (recorded live)
Feb. 2022Important Notices
"Watch the webinar recorded live Nov. 17, 2021, where Alin Severance, MD, medical director of Behavioral Health Services at UPMC Health Plan and associate medical director at Community Care Behavioral Health Organization, discusses the importance of pediatric behavioral health best practices for primary care.
During this hourlong session, Dr. Severance reviews the epidemiology of behavioral health conditions in children and adolescents, best practices for screening and treatment for the most common behavioral health disorders and when to seek referrals, and the range of referral and consultation resources available to support the care of pediatric patients.
Register or log in
You may earn continuing medical education (CME) credits for attending this webinar.*
*This activity is approved for the following credit: AMA PRA Category 1 Credit™ and ANCC. Other health care professionals will receive a certificate of attendance confirming the number of contact hours commensurate with the extent of participation in this activity.
*Provider is responsible for verifying CME eligibility."
During this hourlong session, Dr. Severance reviews the epidemiology of behavioral health conditions in children and adolescents, best practices for screening and treatment for the most common behavioral health disorders and when to seek referrals, and the range of referral and consultation resources available to support the care of pediatric patients.
Register or log in
You may earn continuing medical education (CME) credits for attending this webinar.*
*This activity is approved for the following credit: AMA PRA Category 1 Credit™ and ANCC. Other health care professionals will receive a certificate of attendance confirming the number of contact hours commensurate with the extent of participation in this activity.
*Provider is responsible for verifying CME eligibility."
Recent Announcements
Voluntary nationwide recall: Famotidine (Fresenius – November)
Fresenius Kabi USA, LLC is recalling three lots (6133156, 6133194, and 6133388) of Famotidine Injection, USP, 20 mg per 2 mL. Famotidine is used to treat excessive secretion of stomach acid or stomach ulcers.Nov. 2025Pharmacy Updates
Medicaid provider update: High-cost Medicaid drug billing
Billing requirements for Medicaid-covered drugsNov. 2025Important Notices
Training Webinar: Conversio Health COPD Management Program
Please join us for a live training webinar for primary care providers and pulmonologists by UPMC Health Plan that will provide an overview of a comprehensive COPD management program from Conversio Health.Nov. 2025Education/Webinars